Interchangeability of patient pain, fatigue and global scores in patients with spondyloarthritis - a registry-based simulation study
Status PubMed-not-MEDLINE Jazyk angličtina Země Velká Británie, Anglie Médium electronic
Typ dokumentu časopisecké články
PubMed
40598662
PubMed Central
PMC12217374
DOI
10.1186/s41927-025-00527-6
PII: 10.1186/s41927-025-00527-6
Knihovny.cz E-zdroje
- Klíčová slova
- Missing data, Patient reported outcomes, Registry data, Single imputation, Spondyloarthritis,
- Publikační typ
- časopisecké články MeSH
BACKGROUND: To investigate a patient-level single imputation approach for patient reported outcomes (PROs) that express similar contents or associated PROs, where a PRO whose value is missing at a particular timepoint is substituted by another PRO whose value is available at the same timepoint. METHODS: We performed a simulation study on registry-based spondyloarthritis data to explore the potential interchangeability between the patient pain (PPA) and fatigue (PFA) assessment scores and relevant Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) individual questions, and between PPA, PFA and patient global assessment (PGA). Performance was assessed per imputation method in terms of relative bias and coverage. Sample size, level of missingness and missing data pattern were included as parameters in the simulations. RESULTS: All applied scenarios to interchange PPA with BASDAI question 2 (axial pain), BASDAI question 3 (peripheral joint pain/swelling) or their average failed. Interchangeability between PFA and BASDAI question 1 (fatigue/tiredness) was acceptable for partially (up to 50%) missing data. When interchanging patient assessment scores (PPA, PFA and PGA), we observed inconsistent results in terms of performance. The performance of the applied methods depended on the sample size and the level of missingness, but not heavily on the underlying missing data pattern. CONCLUSIONS: Interchanging PFA and the BASDAI fatigue question was justified for partially missing data, while interchangeability between PPA, PFA and PGA, and between PPA and the BASDAI pain questions was not advised. Our findings suggest that registering patient assessment scores and BASDAI questions is recommended.
Aberdeen Centre for Arthritis and Musculoskeletal Health University of Aberdeen Aberdeen UK
Amsterdam Rheumatology Immunology Center Reade and Amsterdam UMC Amsterdam Netherlands
Center for Treatment of Rheumatic and Musculoskeletal Diseases Diakonhjemmet Hospital Oslo Norway
Centre for Rheumatology Research Landspitali University Hospital Reykjavik Iceland
Clinical Epidemiology Division Department of Medicine Solna Karolinska Institutet Stockholm Sweden
Department of Clinical Medicine Aarhus University Aarhus Denmark
Department of Clinical Medicine University of Copenhagen Copenhagen Denmark
Department of Internal Medicine Dermatology and Psychiatry Universidad de La Laguna La Laguna Spain
Department of Rheumatology 1st Faculty of Medicine Charles University Prague Czech Republic
Department of Rheumatology Aarhus University Hospital Aarhus Denmark
Department of Rheumatology Geneva University Hospital Geneva Switzerland
Department of Rheumatology Hospital Garcia de Orta Almada Portugal
Department of Rheumatology Hospital General Universitario Gregorio Marañón Madrid Spain
Department of Rheumatology Kuopio University Hospital Kuopio Finland
Department of Rheumatology University Hospital Zurich University of Zurich Zurich Switzerland
Department of Rheumatology University Medical Centre Ljubljana Ljubljana Slovenia
EpiDoC Unit CEDOC Nova Medical School Lisbon Portugal
Faculty of Medicine Complutense University of Madrid Madrid Spain
Faculty of Medicine University of Iceland Reykjavik Iceland
Faculty of Medicine University of Ljubljana Ljubljana Slovenia
Institute of Rheumatology Prague Czech Republic
Research Unit Sørlandet Hospital Kristiansand Norway
Rheumatology Service Hospital Universitario de Canarias La Laguna Spain
Rheumatology Unit Hospital dos Lusíadas Lisbon Portugal
Statistics Group Swiss Clinical Quality Management Foundation Zurich Switzerland
Zobrazit více v PubMed
Nhan DT, Caplan L. Patient-Reported outcomes in axial spondyloarthritis. Rheumatic Disease Clin North Am. 2016;42(2):285–99. PubMed
Orbai AM, Ogdie A. Patient-Reported outcomes in psoriatic arthritis. Rheumatic Disease Clin North Am. 2016;42(2):265–83. PubMed PMC
Png K, Kwan YH, Leung YY, Phang JK, Lau JQ, Lim KK, et al. Measurement properties of patient reported outcome measures for spondyloarthritis: A systematic review. Semin Arthritis Rheum. 2018;48(2):274–82. PubMed
Torre-Alonso JC, Queiro R, Comellas M, Lizán L, Blanch C. Patient-reported outcomes in European spondyloarthritis patients: a systematic review of the literature. Patient Prefer Adherence. 2018;12:733–47. PubMed PMC
Sieper J, Rudwaleit M, Baraliakos X, Brandt J, Braun J, Burgos-Vargas R, et al. The assessment of spondyloarthritis international society (ASAS) handbook: A guide to assess spondyloarthritis. Ann Rheum Dis. 2009;68:ii1–44. PubMed
Orbai AM, De Wit M, Mease P, Shea JA, Gossec L, Leung YY, et al. International patient and physician consensus on a psoriatic arthritis core outcome set for clinical trials. Ann Rheum Dis. 2017;76(4):673–80. PubMed PMC
Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A. A new approach to defining disease status in ankylosing spondylitis: the bath ankylosing spondylitis disease activity index. J Rheumatol. 1994;21(12):2286–91. PubMed
Lukas C, Landewé R, Sieper J, Dougados M, Davis J, Braun J, et al. Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis. Ann Rheum Dis. 2009;68(1):18–24. PubMed
Schoels M, Aletaha D, Funovits J, Kavanaugh A, Baker D, Smolen JS. Application of the DAREA/DAPSA score for assessment of disease activity in psoriatic arthritis. Ann Rheum Dis. 2010;69(8):1441–7. PubMed
van der Heijde D, Molto A, Ramiro S, Braun J, Dougados M, van Gaalen F, et al. Goodbye to the term ‘ankylosing spondylitis’, hello ‘axial spondyloarthritis’: time to embrace the ASAS-defined nomenclature. Ann Rheum Dis. 2024;83:547–9. PubMed
Calvert M, Blazeby J, Altman DG, Revicki DA, Moher D, Brundage MD. Reporting of patient-reported outcomes in randomized trials: the CONSORT PRO extension. JAMA - J Am Med Association. 2013;309(8):814–22. PubMed
Bell ML, Fairclough DL. Practical and statistical issues in missing data for longitudinal patient-reported outcomes. Stat Methods Med Res. 2014;23(5):440–59. PubMed
Donders ART, van der Heijden GJMG, Stijnen T, Moons KGM. Review: A gentle introduction to imputation of missing values. J Clin Epidemiol. 2006;59(10):1087–91. PubMed
Pedersen AB, Mikkelsen EM, Cronin-Fenton D, Kristensen NR, Pham TM, Pedersen L, et al. Missing data and multiple imputation in clinical epidemiological research. Clin Epidemiol. 2017;9:157–66. PubMed PMC
Lee KJ, Tilling KM, Cornish RP, Little RJA, Bell ML, Goetghebeur E, et al. Framework for the treatment and reporting of missing data in observational studies: the treatment and reporting of missing data in observational studies framework. J Clin Epidemiol. 2021;134:79–88. PubMed PMC
Eekhout I, De Boer RM, Twisk JWR, De Vet HCW, Heymans MW. Missing data: A systematic review of how they are reported and handled. Epidemiology. 2012;23(5):729–32. PubMed
Schafer JL, Graham JW. Missing data: our view of the state of the Art. Psychol Methods. 2002;7(2):147–77. PubMed
Hayati Rezvan P, Lee KJ, Simpson JA. The rise of multiple imputation: A review of the reporting and implementation of the method in medical research data collection, quality, and reporting. BMC Med Res Methodol. 2015;15(1):1–14. PubMed PMC
Engels JM, Diehr P. Imputation of missing longitudinal data: A comparison of methods. J Clin Epidemiol. 2003;56(10):968–76. PubMed
Sterne JAC, White IR, Carlin JB, Spratt M, Royston P, Kenward MG, et al. Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ (Online). 2009;339(7713):157–60. PubMed PMC
Lauper K, Kedra J, De Wit M, Fautrel B, Frisell T, Hyrich KL, et al. Analysing and reporting of observational data: A systematic review informing the EULAR points to consider when analysing and reporting comparative effectiveness research with observational data in rheumatology. RMD Open. 2021;7(3):1–9. PubMed PMC
Ibrahim F, Tom BDM, Scott DL, Prevost AT. A systematic review of randomised controlled trials in rheumatoid arthritis: the reporting and handling of missing data in composite outcomes. Trials. 2016;17:272. PubMed PMC
Khan NA, Torralba KD, Aslam F. Missing data in randomised controlled trials of rheumatoid arthritis drug therapy are substantial and handled inappropriately. RMD Open. 2021;7:e001708. PubMed PMC
Khan NA, Spencer HJ, Abda E, Aggarwal A, Alten R, Ancuta C, et al. Determinants of discordance in patients’ and physicians’ rating of rheumatoid arthritis disease activity. Arthritis Care Res (Hoboken). 2012;64(2):206–14. PubMed PMC
Desthieux C, Hermet A, Granger B, Fautrel B, Gossec L. Patient-Physician discordance in global assessment in rheumatoid arthritis: A systematic literature review with Meta-Analysis. Arthritis Care Res (Hoboken). 2016;68(12):1767–73. PubMed
Pollard LC, Choy EH, Gonzalez J, Khoshaba B, Scott DL. Fatigue in rheumatoid arthritis reflects pain, not disease activity. Rheumatology. 2006;45(7):885–9. PubMed
Ørnbjerg LM, Brahe CH, Askling J, Ciurea A, Mann H, Onen F, et al. Treatment response and drug retention rates in 24 195 biologic-naïve patients with axial spondyloarthritis initiating TNFi treatment: routine care data from 12 registries in the EuroSpA collaboration. Ann Rheum Dis. 2019;78(11):1536–44. PubMed
Brahe CH, Ørnbjerg LM, Jacobsson L, Nissen MJ, Kristianslund EK, Mann H, et al. Retention and response rates in 14 261 PsA patients starting TNF inhibitor treatment - Results from 12 countries in EuroSpA. Rheumatology. 2020;59(7):1640–50. PubMed
Christiansen SN, Ørnbjerg LM, Rasmussen SH, Loft AG, Askling J, Iannone F et al. European bio-naïve spondyloarthritis patients initiating TNF inhibitor: time trends in baseline characteristics, treatment retention and response. Rheumatology. 2021. PubMed
Burton A, Altman DG, Royston P, Holder RL. The design of simulation studies in medical statistics. Stat Med. 2006;25(24):4279–92. PubMed
Morris TP, White IR, Crowther MJ. Using simulation studies to evaluate statistical methods. Stat Med. 2019;38(11):2074–102. PubMed PMC
Rubin DB. Inference and missing data. Biometrika. 1976;63(3):581–92.
Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983;70(1):41–55.
Tillé Y. Sampling and Estimation from finite populations. Hoboken, NJ: Wiley; 2020.
Nikiphorou E, Radner H, Chatzidionysiou K, Desthieux C, Zabalan C, van Eijk-Hustings Y, et al. Patient global assessment in measuring disease activity in rheumatoid arthritis: A review of the literature. Arthritis Res Ther. 2016;18:251. PubMed PMC
Deodhar AA, Mease PJ, Rahman P, Navarro-Compán V, Strand V, Hunter T et al. Ixekizumab improves spinal pain, function, fatigue, stiffness, and sleep in radiographic axial spondyloarthritis: COAST-V/W 52-week results. BMC Rheumatol. 2021;5(35). PubMed PMC
van der Heijden GJMG, Donders T, Stijnen AR, Moons T. Imputation of missing values is superior to complete case analysis and the missing-indicator method in multivariable diagnostic research: A clinical example. J Clin Epidemiol. 2006;59(10):1102–9. PubMed
Ambler G, Omar RZ, Royston P. A comparison of imputation techniques for handling missing predictor values in a risk model with a binary outcome. Stat Methods Med Res. 2007;16(3):277–98. PubMed
White IR, Royston P, Wood AM. Multiple imputation using chained equations: issues and guidance for practice. Stat Med. 2011;30(4):377–99. PubMed